Dr. Lal PathLabs (NSE:LALPATHLAB) 3-Year Book Growth Rate : 14.20% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Dr. Lal PathLabs 3-Year Book Growth Rate?

Dr. Lal PathLabs's Book Value per Share for the quarter that ended in Mar. 2024 was ₹222.24.

During the past 12 months, Dr. Lal PathLabs's average Book Value per Share Growth Rate was 10.60% per year. During the past 3 years, the average Book Value per Share Growth Rate was 14.20% per year. During the past 5 years, the average Book Value per Share Growth Rate was 15.40% per year. During the past 10 years, the average Book Value per Share Growth Rate was 22.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Dr. Lal PathLabs was 43.60% per year. The lowest was 14.20% per year. And the median was 26.20% per year.

Competitive Comparison of Dr. Lal PathLabs's 3-Year Book Growth Rate

For the Diagnostics & Research subindustry, Dr. Lal PathLabs's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr. Lal PathLabs's 3-Year Book Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr. Lal PathLabs's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Dr. Lal PathLabs's 3-Year Book Growth Rate falls into.

Dr. Lal PathLabs 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Dr. Lal PathLabs (NSE:LALPATHLAB) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Dr. Lal PathLabs 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Dr. Lal PathLabs's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr. Lal PathLabs (NSE:LALPATHLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

539524:India

Address

12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001

Website

https://www.lalpathlabs.com

Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.

Dr. Lal PathLabs (NSE:LALPATHLAB) Headlines

No Headlines